BNP Paribas Financial Markets
CARL

BNP Paribas Financial Markets’s Carlsmed CARL Stock Holding History

BNP Paribas Financial Markets’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.2K Buy
2,567
+417
+19% +$5.04K ﹤0.01% 5045
2025
Q4 		$26.6K Sell
2,150
-350
-14% -$4.66K ﹤0.01% 4941
2025
Q3 		$33.5K Buy
+2,500
New +$34.2K ﹤0.01% 4765

Other funds holding CARL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KC
KCM Capital Shawnee, Kansas $622M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets's CARL Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Carlsmed (CARL) stake by 19% in Q1 2026, buying an estimated $5.04K and bringing the position to 2,567 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5045.

BNP Paribas Financial Markets first reported a position in CARL in Q3 2025 and has held it in 3 quarters since. The position peaked at $33.5K in Q3 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • BNP Paribas Financial Markets held 2,567 shares of Carlsmed worth $23.2K as of Q1 2026.
  • BNP Paribas Financial Markets bought 417 Carlsmed shares in Q1 2026, an estimated $5.04K.
  • Carlsmed made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5045 holding.
  • BNP Paribas Financial Markets first reported a position in Carlsmed in Q3 2025 and has held it in 3 quarters since.
  • BNP Paribas Financial Markets's Carlsmed position peaked at $33.5K in Q3 2025.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.